BARDA Award to UMSOM Aims to Advance Radiation Medical Countermeasures Medical Countermeasures February 26, 2024 …
BARDA Looks to Advance Metagenomic Next-Generation Sequencing (mNGS) Biodetection February 12, 2024 …
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024 …
BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy Medical Countermeasures January 23, 2024 …
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
Inflammatix Completes Development for Acute Infection and Sepsis Test System Biodetection November 15, 2023 …
HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
Protection from Biothreats: DOD to Modernize Medical Countermeasures Development CBRNE January 10, 2023 …